The aScope 4 Broncho from Ambu A/ S - single-use bronchoscopy for tight ICU schedules

Reviewed: ad hoc news Bestseller & Flagship desk. Edited and checked on 2026-06-29, 08:19. Details in the imprint.

The aScope 4 Broncho sits in a nurse’s gloved hand like a light, flexible cable, the sterile packaging crackling just seconds before an ICU patient needs a check of their airways. No reprocessing queue, no hunting for a clean scope, just open, connect and go.

What the scope delivers

Ambu A/S positions the aScope 4 Broncho as a single-use flexible bronchoscope designed for ICU and OR workflows, available in several diameters to match different patient sizes. It connects to Ambu’s visualization platforms to give clinicians full-color images and video recording at the bedside.

The disposable design means each bronchoscopy starts with a fresh device, reducing cross-contamination risk compared with reusable scopes and eliminating the cost and logistics of cleaning and disinfection. Hospitals swap reprocessing rooms and repair tickets for a cart stocked with individually packed scopes.

How it changes daily work

In practice, intensivist Dr. Lars Rasmussen describes the aScope 4 Broncho as “a quiet helper” that lets his team perform bedside bronchoscopy even in the middle of the night when central endoscopy units are closed. The tactile grip and predictable stiffness make steering through the trachea feel controlled rather than vague.

Nurses report that setup involves connecting the scope to the monitor, confirming image quality and performing a quick leak check, with no need for tracking tags or reprocessing forms. Once the procedure is done, the scope goes straight into clinical waste, freeing staff from turnaround calculations.

Sizes, screens and suction

The aScope 4 Broncho family typically includes slim versions for pediatric or narrow airways and larger versions for adult patients, giving clinicians options instead of forcing one diameter on every case. Scope channels allow suction and instillation, so doctors can remove secretions while visualizing the bronchial tree.

On Ambu’s own displays, the image appears bright and reasonably sharp, with on-screen tools to capture stills and clips for documentation. That means an ICU resident can review the footage with a senior physician minutes later rather than relying on memory and sketchy diagrams.

Why single-use matters

Ambu has made single-use endoscopy a strategic focus, arguing that disposable scopes simplify infection control and avoid hidden costs of cleaning, repairs and loaner devices. For infection prevention teams, the logic is consistent: one patient, one sterile scope, no reprocessing history to audit.

Reprocessing of reusable bronchoscopes can involve chemical disinfectants, drying cabinets, tracking systems and periodic microbiological cultures. Each step introduces potential gaps; single-use devices sidestep this chain, though at the cost of more clinical waste and a new procurement line.

Cost and procurement friction

From a hospital purchasing view, the aScope 4 Broncho turns capital expenditure into operating expenditure. Instead of buying a few expensive reusable scopes and washers, facilities buy boxes of disposables and budget per procedure.

That shift can be sobering for financial controllers. They must compare per-use costs, repair budgets, staff time and infection-related incident costs to see whether single-use bronchoscopy is economically convincing in their setting, rather than assuming disposable equals more expensive by default.

Environmental trade-offs

The environmental footprint is where single-use endoscopy draws criticism. Each aScope 4 Broncho ends as clinical waste, adding plastic and electronics to incineration streams. Sustainability managers will ask Ambu how it plans to mitigate this impact through design or recycling schemes.

Ambu highlights that avoiding infections and device-related cross-contamination can save resources, but those benefits are hard to weigh against visible bins full of discarded scopes. Some hospitals test mixed models, using single-use scopes for high-risk cases and reusable ones for standard procedures.

Clinician feedback and limits

In user reports, clinicians praise the predictable availability of the aScope 4 Broncho during bronchoscopy for intubated patients and for removal of mucus plugs. They also note that image quality, while clinically adequate, may not match premium reusable scopes for complex, fine-detail diagnostics.

Procedural limits matter: for advanced interventions such as endobronchial biopsies or stent placement, hospitals may still rely on higher-end reusable systems. The aScope 4 Broncho occupies a pragmatic niche, focused on bedside procedures and quick checks rather than every possible bronchoscopic task.

Regulation and training

As a medical device, the aScope 4 Broncho is marketed under regulatory approvals that define its intended use and training requirements. Ambu provides instructions for use and educational material to ensure clinicians understand the handling, indications and disposal steps.

Training typically covers insertion technique, navigation in the bronchial tree, suction handling and troubleshooting of image or connection issues. Because the device is single-use, there is less emphasis on maintenance, but more on correct disposal and stock rotation.

Where Ambu shares fit in

For Ambu, the aScope 4 Broncho is part of a broader single-use endoscopy portfolio that underpins its strategy and attracts investor attention. Ambu A/S shares (ISIN DK0060946788) trade on Nasdaq Copenhagen, where the single-use push is a key element of the company’s equity story.

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.

en | DK0060946788 | AMBU | boerse | 69650405 | bgmi